Interleukin-1β rapidly inhibits aortic endothelium-dependent relaxation by a DNA transcription-dependent mechanism
- 1 March 2003
- journal article
- laboratory investigations
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 31 (3) , 910-915
- https://doi.org/10.1097/01.ccm.0000053516.15727.e5
Abstract
Objectives This study examined the effects of interleukin-1β on isometric tension development and relaxation in isolated rat aortic rings in response to the α-1 adrenergic agonist phenylephrine, the endothelium-dependent vasodilator acetylcholine, and the endothelium-independent vasodilator sodium nitroprusside. Design Randomized, controlled, paired design. Setting Animal laboratory within a university department of physiology. Subjects Paired ex vivo aortic thoracic aortic rings from specific pathogen-free Sprague-Dawley rats. Interventions Series I examined the potential for interleukin-1β to cause early arterial endothelial dysfunction. Paired aortic rings were incubated for 2 hrs with interleukin-1β or vehicle. Series II examined the potential for inhibition of DNA transcription to attenuate interleukin-1β-mediated endothelial dysfunction. Paired rings received either dactinomycin or vehicle before interleukin-1β incubation. Series III quantified the degree to which inhibition of DNA transcription inhibited early interleukin-1β-mediated endothelial dysfunction. Paired rings received either dactinomycin pretreatment followed by interleukin-1β incubation, or pretreatment and incubation with inert vehicles. Series IV assessed the effects of interleukin-1β on responsiveness to an exogenous nitric oxide donor, sodium nitroprusside, in the presence of the nitric oxide synthesis inhibitor Nω-nitro-L-arginine methyl ester. Measurements and Main Results Incubation with interleukin-1β for 2 hrs had no effect on contractile response but attenuated endothelium-dependent relaxation significantly relative to control. Dactinomycin pretreatment inhibited early interleukin-1β-mediated endothelial dysfunction. The combination of interleukin-1β and dactinomycin produced effects on endothelium-dependent relaxation that were not different from that seen in rings not exposed to interleukin-1β. Interleukin-1β attenuated responsiveness to sodium nitroprusside relative to control. Conclusions Interleukin-1β causes an early impairment of endothelium-dependent vasorelaxation with an onset that precedes its effects on systemic contractility. This impairment occurs via a mechanism that is wholly or predominantly dependent on DNA transcription. The altered vasorelaxation induced by interleukin-1β is at least partly mediated by a reduction in nitric oxide responsiveness.Keywords
This publication has 20 references indexed in Scilit:
- Confirmatory interleukin-1 receptor antagonist trial in severe sepsisCritical Care Medicine, 1997
- Endothelial modification of pulmonary vascular toneIntensive Care Medicine, 1996
- Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trialCritical Care Medicine, 1994
- Human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndromeCritical Care Medicine, 1994
- Endotoxin-induced organ injuryCritical Care Medicine, 1993
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.Journal of Clinical Investigation, 1992
- Interleukin-1 impairs both vascular contraction and relaxation in rabbit isolated aortaBiochemical and Biophysical Research Communications, 1992
- Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin FeverThe Journal of Infectious Diseases, 1990
- Interleukin 1 inhibits contraction of vascular smooth muscle.Journal of Clinical Investigation, 1989